Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)-Pilot Trial

NCT05148715 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT05148715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05148715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)-Pilot Trial
Lead sponsor
Université de Sherbrooke
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 11, 2022
Completion date
January 31, 2026
Enrollment
414 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

brain death, ischemic reperfusion injury, organ transplant failure or rejection